Despite a nationwide halt to outdoor activities and gym attendance in 2020, analgesics recorded solid single-digit growth. The category’s performance was largely attributed to widespread stockpiling, particularly of Tylenol, due to COVID-19 and everyday pain relief needed for a sedentary at-home lifestyle. While the reactionary demand for analgesics due to panic-buying has subsided, the continuous pains arising due to working from home, the rising number of COVID-19 infections, and the return to...

Euromonitor International’s Analgesics in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years’ experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.